Related news archives

As Compounding Obstacles Increase, ASRS Voices Concerns and Additional Recommendations to New FDA Compounding Chief - Jun 8, 2016

ASRS to Comment at Upcoming FDA Listening Session on Drug Compounding - Jun 1, 2016

New FDA Guidance Requires Patient-Specific Prescriptions for Drugs Compounded by Traditional Compounders for Office Use - Apr 20, 2016

ASRS Urges USP to Stick with Science for Establishing BUDs - Feb 2, 2016

Avastin Coding Changes in Effect for 19 States, 3 Territories - Jan 6, 2016 

Take Action to Preserve Access to Avastin - Apr 16, 2015

ASRS Joins Coalition Effort to Allow States to Govern Office Use of Compounded Drugs - Mar 18, 2015

ASRS Concerned About Short Beyond-Use Dates in FDA Draft Guidance - Feb 18, 2015

Ophthalmology Fighting for a Seat at the Table as FDA Implements Compounding Regulations -Feb 16, 2015

ASRS Urges Congress to Protect Patient Access to Compounded Drugs - Dec 23, 2014

ASRS Launches Updated Compounding Pharmacy Questionnaire to Assist Members in Evaluating Compounders - Sep 24, 2014

Despite Guidance Setback, ASRS Continues to Push for Access to Avastin - Jul 9, 2014

FDA Guidance on Compounded Drugs Limits Distribution for Office Use to Approved Outsourcing Facilities - Jul 2, 2014

ASRS Call to Action: Ask Congress to Support Letter to FDA on Pharmacy Compounding - Jun 19, 2014

FDA Issues Warning Letters to 4 Compounding Pharmacies - Mar 12, 2014

FDA Issues Some Guidance Related to the Drug Quality and Security Act: Long-Term Availability of Avastin Remains Uncertain - Feb 26, 2014

FDA Alert: Abrams Royal Pharmacy Recalls Sterile Compounded Products - Dec 19, 2013

FDA, Congress Seek Stronger Authority for FDA Over Compounding Pharmacies - Dec 1, 2013

Obama Signs Drug Quality and Security Act - Nov 30, 2013

FDA Alert: Nature's Pharmacy & Compounding Center of North Carolina Recalls Sterile Compounded Products - Nov 18, 2013

FDA Alert: Michigan's Specialty Medicine Compounding Pharmacy Recalls Bevacizumab - Oct 21, 2013

Compounding Clarity Act Could Replace Section 503A of Food, Drug and Cosmetic Act - Sep 12, 2013

FDA Alert: Leiter's Compounding Pharmacy Recalls Bevacizumab, Lidocaine/Phenylephrine - Sep 11, 2013

FDA Alert: Avella Specialty Pharmacy Recalls Avastin - Sep 9, 2013

FDA Alert: Specialty Compounding in Cedar Park, Texas Recalls Sterile Products - Aug 11, 2013

Revised Senate Compounding Bill Reflects Major Win for Ophthalmology- Aug 6, 2013

Michigan's Beacon Hill Medical Pharmacy/Rxtra Solutions Recalls Sterile Injectables - Aug 1, 2013

FDA Update: Adverse Reactions Reported to Steroid Injections from Tennessee's Main Street Family Pharmacy - Jun 7, 2013

Tennessee's Main Street Family Pharmacy Recalls All Sterile Products - May 28, 2013

Tennessee's Main Street Family Pharmacy Reports Adverse Reactions to Steroid Injections -May 24, 2013

FDA Alert: NuVision Pharmacy in Dallas Lacks Sterility Assurance - May 18, 2013

FDA Alert: The Compounding Shop Lacks Sterility Assurance - May 8, 2013

FDA Cites 30 of 31 Compounding Pharmacies Following Inspections - Apr 12, 2013

Pallimed Solutions Voluntarily Recalls Sterile Compounded Products - Mar 25, 2013

Clinical Specialties Compounding Pharmacy Recalling All Sterile Products - Mar 21, 2013

California Legislation Calls for Sterile Compounding Pharmacy Licensing, Nonresident Inspections - Mar 18, 2013

New Hampshire Bill Would Safeguard Physician Access to Compounded Drugs - Mar 18, 2013

Minnesota Legislation May Require Inspections of Out-of-State Pharmacies, Board Considering Regulations for In-State Compounding - Mar 18, 2013

Clinical Specialties Issues Voluntary Nationwide Recall of Avastin - Mar 18, 2013

ASRS Member Alert - Endophthalmitis Cases Reported - Mar 15, 2013

Tennessee Compounders Could See More Inspections, Lifting of Patient-Specific Prescriptions - Mar 14, 2013

Draft Legislation on Compounding Pharmacies in Process - Mar 12, 2013

Oklahoma Legislation Could Impact Out-of-State Compounding Pharmacies Mar 6, 2013

Washington State Board of Pharmacy: Practitioners Can Administer Compounded Products Without a Patient-Specific Prescription - Mar 5, 2013

Only 4 of 37 Massachusetts Compounding Pharmacies Pass Surprise State Inspections - Mar 5, 2013

New Jersey Legislation Would Require Accreditation of Compounding Pharmacies - Mar 5, 2013

FDA Targeting About 30 Compounding Pharmacies With Inspections, Issues Reports on 4 - Mar 5, 2013

New England Compounding Center Meningitis Outbreak Update - Dec 17, 2012

15 States Tighten Regulations on Compounding Pharmacies - Nov 14, 2012

Two Additional Recalls From New England Compounding Center - Nov 2, 2012

FDA Publishes Lists of New England Compounding Center Customers - Oct 24, 2012

FDA Publishes Lists of New England Compounding Center Customers - Oct 24, 2012

FDA Advises Retina Specialists: Notify Patients Treated with Drugs Purchased from New England Compounding Center - Oct 16, 2012

Compounding Pharmacies—What You Need to Know - Oct 13, 2012

CDC and FDA Caution Retina Specialists: Stop Using Drugs from New England Compounding Center - Oct 8, 2012

MMWR Notes and CDC Talking Points from the Field: Fungal Endophthalmitis - May 4, 2012

A Review of the Frequency and Possible Pathogenesis of Sterile Endophthalmitis Associated with Intravitreal Injections - Apr 13, 2012

Verifying the Source of Compounded Bevacizumab for Intravitreal Injections - Mar 2, 2012

Recent Avastin Compounding Related Events - Sep 7, 2011